8XFW image
Deposition Date 2023-12-14
Release Date 2024-12-18
Last Version Date 2025-07-09
Entry Detail
PDB ID:
8XFW
Keywords:
Title:
Crystal structure of MiCGT(M148A/V190T/S121D) in complex with UDP
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.10 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:UDP-glycosyltransferase 13
Gene (Uniprot):CGT
Mutations:S121P, M148A, V190T
Chain IDs:A, B
Chain Length:459
Number of Molecules:2
Biological Source:Mangifera indica
Ligand Molecules
Primary Citation
An efficient C-glycoside production platform enabled by rationally tuning the chemoselectivity of glycosyltransferases.
Nat Commun 15 8893 8893 (2024)
PMID: 39406733 DOI: 10.1038/s41467-024-53209-1

Abstact

Despite the broad potential applications of C-glycosides, facile synthetic methods remain scarce. Transforming glycosyltransferases with promiscuous or natural O-specific chemoselectivity to C-glycosyltransferases is challenging. Here, we employ rational directed evolution of the glycosyltransferase MiCGT to generate MiCGT-QDP and MiCGT-ATD mutants which either enhance C-glycosylation or switch to O-glycosylation, respectively. Structural analysis and computational simulations reveal that substrate binding mode govern C-/O-glycosylation selectivity. Notably, directed evolution and mechanism analysis pinpoint the crucial residues dictating the binding mode, enabling the rational design of four enzymes with superior non-inherent chemoselectivity, despite limited sequence homology. Moreover, our best mutants undergo testing with 34 substrates, demonstrating superb chemoselectivities, regioselectivities, and activities. Remarkably, three C-glycosides and an O-glycoside are produced on a gram scale, demonstrating practical utility. This work establishes a highly selective platform for diverse glycosides, and offers a practical strategy for creating various types of glycosylation platforms to access pharmaceutically and medicinally interesting products.

Legend

Protein

Chemical

Disease

Primary Citation of related structures